8S1X

Crystal structure of Actinonin-bound PDF1 and the computationally designed DBAct553_1 protein binder

8S1X の概要

• エントリーDOI: 10.2210/pdb8s1x/pdb
• 分子名称: Peptide deformylase, DBAct553_1, ZINC ION, ... (8 entities in total)
• 機能のキーワード: actinonin, de novo, computational, binder, cid, switch, deformylase, de novo protein
• 由来する生物種: Pseudomonas aeruginosa; 詳細
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 28781.60

構造登録者

Marchand, A.,Pacesa, M.,Correia, B.E. (登録日: 2024-02-16, 公開日: 2024-10-30, 最終更新日: 2025-03-26)

主引用文献

Marchand, A.,Buckley, S.,Schneuing, A.,Pacesa, M.,Elia, M.,Gainza, P.,Elizarova, E.,Neeser, R.M.,Lee, P.W.,Reymond, L.,Miao, Y.,Scheller, L.,Georgeon, S.,Schmidt, J.,Schwaller, P.,Maerkl, S.J.,Bronstein, M.,Correia, B.E.
Targeting protein-ligand neosurfaces with a generalizable deep learning tool.
Nature, 639:522-531, 2025

PubMed Abstract: Molecular recognition events between proteins drive biological processes in living systems. However, higher levels of mechanistic regulation have emerged, in which protein-protein interactions are conditioned to small molecules. Despite recent advances, computational tools for the design of new chemically induced protein interactions have remained a challenging task for the field. Here we present a computational strategy for the design of proteins that target neosurfaces, that is, surfaces arising from protein-ligand complexes. To develop this strategy, we leveraged a geometric deep learning approach based on learned molecular surface representations and experimentally validated binders against three drug-bound protein complexes: Bcl2-venetoclax, DB3-progesterone and PDF1-actinonin. All binders demonstrated high affinities and accurate specificities, as assessed by mutational and structural characterization. Remarkably, surface fingerprints previously trained only on proteins could be applied to neosurfaces induced by interactions with small molecules, providing a powerful demonstration of generalizability that is uncommon in other deep learning approaches. We anticipate that such designed chemically induced protein interactions will have the potential to expand the sensing repertoire and the assembly of new synthetic pathways in engineered cells for innovative drug-controlled cell-based therapies.

PubMed: 39814890
DOI: 10.1038/s41586-024-08435-4

実験手法

X-RAY DIFFRACTION (1.88 Å)